A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene-related peptide ligand (galcanezumab) or receptor (erenumab) antagonist - Kudrow, D; Nguyen, L; Semler, J (Headache, 2022)
et al.